Hence, for evaluating the potential of FBXO5 in guiding clinical treatment, the correlation between FBXO5 and drug resistance of tumor cells was computed based upon IC50 values of drugs along with FBXO5 expression levels. The gene discussed is FBXO5; the disease is neoplasm.